SCHEMBL10550302

SCHEMBL10550302

CC(C)(C)C1OCC(C/C=C\CCC(=O)NS(C)(=O)=O)C(c2ccccc2O)O1

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.57
▸ CYP3A4 P08684 2/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ TBXA2R P21731 5/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ TBXAS1 P24557 14/20 0.49
▸ PTGIS Q16647 6/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10337172 0.89 TBXAS1 (0.56) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R
SCHEMBL10550029 0.89 TBXAS1 (0.48) CYP1A2CYP3A4CYP2C9CYP2C19TBXAS1
SCHEMBL10350317 0.86 CYP1A2 (0.72) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R
SCHEMBL10558107 0.83 TBXA2R (0.49) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R
SCHEMBL10337091 0.79 TBXAS1 (0.54) CYP1A2CYP3A4CYP2C9CYP2C19TBXAS1
SCHEMBL10550190 0.76 TBXA2R (0.73) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R
SCHEMBL12675684 0.76 CYP1A2 (0.89) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R
SCHEMBL10465091 0.76 CYP1A2 (0.89) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R
SCHEMBL10401364 0.75 TBXAS1 (0.70) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R
SCHEMBL10401287 0.74 CYP1A2 (0.64) CYP1A2CYP3A4CYP2C9CYP2C19TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4845120-A THROMBOXANE ANTAGONISTS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-07-04 — — US disclosed
EP-0246002-A2 Alkenamide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-11-19 — — EP disclosed
Send feedback